C

Curis
D

CRIS

4.80500
USD
0.17
(3.67%)
مغلق
حجم التداول
2,747
الربح لكل سهم
-21
العائد الربحي
-
P/E
-0
حجم السوق
9,364,628
أصول ذات صلة المقالات
المزيد

العنوان: Curis Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.